Search clinical trials for: Gemcitabine Rituximab
Total 6009 results
-
German Low Grade Lymphoma Study GroupTerminatedIndolent LymphomaGermany
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
Sun Yat-sen UniversityCompletedLymphoma, Large B-Cell, DiffuseChina
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
University of Alabama at BirminghamEli Lilly and CompanyCompletedStage IV Non-Small Cell Lung CancerUnited States
-
Dorte NielsenCompletedCholangiocarcinomaDenmark
-
Auxilio Mutuo Cancer CenterCompletedRefractory Aggressive Non-Hodgkin's Lymphoma | Relapsing Aggressive Non-Hodgkin's Lymphoma
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedMantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | Aggressive LymphomaSpain
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, Canada
-
Lymphoma Study AssociationEli Lilly and Company; Hoffmann-La Roche; Sanofi-SynthelaboCompletedDiffuse Large Cell LymphomaFrance
-
Eli Lilly and CompanyCompletedLymphoma, Large Cell, DiffuseFrance, Germany, Russian Federation
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaboratorsCompletedCholangiocarcinoma | Adenocarcinoma of GallbladderTaiwan
-
Seagen Inc.Genentech, Inc.CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
Miltenyi Biomedicine GmbHICON plcRecruitingDiffuse Large B-cell LymphomaSpain, Germany, Netherlands, Belgium, France, Czechia, Austria, Lithuania, Poland, Sweden, Hungary, Italy
-
National Cancer Institute, NaplesCompletedAdvanced Non-Small Cell Lung CancerItaly
-
Cliniques universitaires Saint-Luc- Université...Merck Sharp & Dohme LLCCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia...CompletedPancreatic CancerCanada, United States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Withdrawn
-
University of Massachusetts, WorcesterCompletedPancreatic Cancer
-
Dartmouth-Hitchcock Medical CenterCompleted
-
University of MiamiWithdrawn
-
Association of Research on the Biology of Liver...Completed
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingNeoplasms by Histologic Type | Lymphoma, Large B-Cell, DiffuseChina
-
US Oncology ResearchEli Lilly and CompanyCompletedRelapsed or Refractory Mantle Cell Lymphoma (MCL)
-
Auxilio Mutuo Cancer CenterUnknown
-
The Lymphoma Academic Research OrganisationPfizerCompletedDiffuse Large B-Cell LymphomaFrance, Belgium
-
Carmen Schade-BrittingerCompleted
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
University of MiamiCompletedPancreatic CancerUnited States
-
Cyteir Therapeutics, Inc.Active, not recruitingSoft Tissue Sarcoma | Follicular Lymphoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Multiple Myeloma | Pancreatic Cancer | Ovarian Cancer | Mantle Cell Lymphoma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | DLBCL | Non-hodgkin Lymphoma | Malignancy | CLLUnited States
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma (CD20+)Australia
-
St. Petersburg State Pavlov Medical UniversityCompletedDiffuse Large B Cell LymphomaRussian Federation
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
CelgeneActive, not recruitingNeoplasmsUnited States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom
-
Universitätsklinikum Hamburg-EppendorfHannover Medical School; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsTerminated
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Mohammed MilhemUniversity of Iowa; Holden Comprehensive Cancer CenterCompletedSarcoma | Pancreatic Ductal AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
Canadian Cancer Trials GroupAbbVie; Roche Pharma AG; Incyte CorporationRecruiting
-
Gyeongsang National University HospitalSamsung Medical Center; Dong-A University; Chung-Ang UniversityTerminatedMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerKorea, Republic of
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
PfizerCompletedRheumatoid ArthritisUnited States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
-
Sun Yat-sen UniversityRecruitingLymphoma, Large B-Cell, DiffuseChina
-
NCIC Clinical Trials GroupCompletedLymphomaUnited States, Canada, Australia
-
Mabion SAParexelWithdrawn